These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24314664)

  • 1. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
    Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
    Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
    Saha A; Bamidele A; Murakami M; Robertson ES
    J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
    Yi F; Saha A; Murakami M; Kumar P; Knight JS; Cai Q; Choudhuri T; Robertson ES
    Virology; 2009 Jun; 388(2):236-47. PubMed ID: 19394062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.
    Saha A; Lu J; Morizur L; Upadhyay SK; Aj MP; Robertson ES
    PLoS Pathog; 2012; 8(3):e1002573. PubMed ID: 22438805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K; Bose D; Singh RK; Pei Y; Robertson ES
    J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.
    Accardi R; Fathallah I; Gruffat H; Mariggiò G; Le Calvez-Kelm F; Voegele C; Bartosch B; Hernandez-Vargas H; McKay J; Sylla BS; Manet E; Tommasino M
    PLoS Pathog; 2013 Mar; 9(3):e1003186. PubMed ID: 23516355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
    J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1.
    Kaul R; Murakami M; Lan K; Choudhuri T; Robertson ES
    J Virol; 2009 May; 83(10):4871-83. PubMed ID: 19116252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.
    Choudhuri T; Verma SC; Lan K; Murakami M; Robertson ES
    J Virol; 2007 Jun; 81(12):6718-30. PubMed ID: 17409144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
    PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation.
    Park GB; Bang SR; Lee HK; Kim D; Kim S; Kim JK; Kim YS; Hur DY
    J Immunother; 2014; 37(6):309-20. PubMed ID: 24911792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.